A Multi-mRNA Prognostic Signature for Anti-TNFα Therapy Response in Patients with Inflammatory Bowel Disease - Inflammatix

Skip to main content Skip to footer

Home
Triverity
Education
Evidence
- Publications
- Abstracts
Pipeline
News
Careers
About
Reach out

Home
Triverity
Education
Evidence
- Publications
- Abstracts
Pipeline
News
Careers
About
Reach out

Sakaram, S. et.al. Diagnostics. Oct 2021.

© Copyright 2025, Inflammatix, Inc. All Rights Reserved | Terms & Conditions | Privacy & Cookies Statement

Inflammatix, TriVerity, Myrna, RespVerity, and BacVerity are trademarks of Inflammatix, Inc.